Oxytocic Pharmaceuticals Market will lead to rise in Cesarean births
Oxytocic Pharmaceuticals Market will lead to rise in Cesarean births
Blog Article
The oxytocic pharmaceuticals market primarily deals with medications that induce or assist in labor contractions and delivery of the fetus or newborn. Oxytocic drugs help to expel the placenta after birth. Oxytocin, methylergonovine, and carboprost are some common oxytocic pharmaceuticals used. These medications are important during preterm labor, postpartum hemorrhage, and medical termination of pregnancy.
Oxytocic Pharmaceuticals Market is estimated to be valued at USD 148.8 Mn in 2025 and is expected to reach USD 251.7 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032..
Key Takeaways
Key players operating in the oxytocic pharmaceuticals market are Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, copyright, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.
The rising number of childbirths globally is a major factor driving the Oxytocic Pharmaceuticals Market Demand. According to the United Nations Population Division, around 140 million births occur each year worldwide. Cesarean section births require the administration of oxytocic drugs to prevent excessive bleeding. Rise in C-sections will boost market growth.
Technological advancements have led to the development of long-acting oxytocin analogs, which induce uterine contraction for an extended period. These analogs provide convenience of less frequent dosing. Lancox etrex and carbetocin are examples of long-acting uterotonics gaining popularity.
Market Trends
Preference for natural oxytocics - Herbal medicines like rue, ergotamine, and blue cohosh have been used as traditional oxytocics. Growing demand for herbal alternatives to allopathic drugs is a key trend.
Increased awareness regarding postpartum hemorrhage prevention - Lack of active management of third stage labor has resulted in a large number of preventable maternal deaths. Greater awareness about administering uterotonics is an important trend.
Market Opportunities
Untapped developing markets - Developing Asian and African countries with high fertility rates offer lucrative opportunities. Access to affordable oxytocics can reduce hemorrhage-related deaths.
Development of novel delivery systems - Innovation in drug delivery through subcutaneous, nasal, buccal, and intramuscular routes can improve accessibility in low-resource environments. This presents opportunities.
Impact of COVID-19 on Oxytocic Pharmaceuticals Market Growth
The outbreak of COVID-19 pandemic has negatively impacted the growth of oxytocic pharmaceuticals market globally. During the pandemic, many people avoided visiting hospitals for childbirth which reduced the demand for oxytocic drugs in 2020. The restrictions on non-emergency medical procedures further declined the usage of oxytocic drugs. However, with widespread vaccination programs in 2021, hospitals resumed normal child delivery services which boosted the demand and sales towards the end of 2021.
It is estimated that in 2022, the oxytocic pharmaceuticals market will show significant growth as the fear of pandemic reduced and people started opting for hospital deliveries. The manufacturers are expanding their production capacities to cater to the increasing needs. The governments are also investing in improving maternal healthcare facilities to enhance access to quality oxytocic drugs. It is expected that in the coming years, as the impact of pandemic diminishes, the market will get back on its pre-COVID growth trajectory and witness steady rise till 2031. The key players are focusing on new product launches and expanding distributions channels globally to tap opportunities arising in the post-COVID scenario.
Geographical Regions with Highest Oxytocic Pharmaceuticals Market Value
North America represents the region with largest market value for oxytocic pharmaceuticals due to high consumption and availability of advanced healthcare facilities. In 2020, the North America oxytocic pharmaceuticals market was valued at US$ 38 Mn. The Europe market holds the second position in terms of value owing to growing awareness about maternal care. The Asia Pacific region is expected to witness fastest value growth during forecast period due to rising birth rates, improving public health systems and increasing expenditure on healthcare in counties like China and India.
Fastest Growing Region for Oxytocic Pharmaceuticals Market
Asia Pacific region is projected to emerge as the fastest growing region for oxytocic pharmaceuticals market during the forecast period of 2024 to 2031. This is attributed to increasing government initiatives for enhancing reproductive and maternal healthcare in developing APAC countries. Also, rising disposable incomes, growing medical tourism and expanding healthcare infrastructure are fueling the demand for oxytocic drugs in Asia Pacific region. It is estimated that the annual growth rate of APAC oxytocic pharmaceuticals market will be around 9.5% over the next 7 years, making it most lucrative geographical market.
Get More Insights - Oxytocic Pharmaceuticals Market
Get This Report in Japanese Language -子宮収縮薬市場
Get This Report in Korean Language -산통제 의약품 시장
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript"> Report this page